Significance of Simpson grading system in modern meningioma surgery: Integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas - Clinical article

Journal of Neurosurgery

Volumn 117, Issue 1, 2012, Pages 121-128

  Oya, Soichi ^a   Kawai, Kensuke ^a   Nakatomi, Hirofumi ^a   Saito, Nobuhito ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Meningioma; MIB 1 labeling index; Oncology; Recurrence; Simpson grade

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER SURGERY; CHILD; FEMALE; FOLLOW UP; HUMAN; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; SCHOOL CHILD; SCORING SYSTEM; SIMPSON GRADING SYSTEM; TUMOR LOCALIZATION; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DATA INTERPRETATION, STATISTICAL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; MAGNETIC RESONANCE IMAGING; MALE; MENINGIOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEUROSURGICAL PROCEDURES; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 84863471335     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2012.3.JNS111945     Document Type: Article

References (42)

1. Abramovich CM, Prayson RA: Histopathologic features and MIB-1 labeling indices in recurrent and nonrecurrent meningiomas. Arch Pathol Lab Med 123:793-800, 1999 (Pubitemid 29409542)
2. Adegbite AB, Khan MI, Paine KW, Tan LK: The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg 58:51-56, 1983 (Pubitemid 13220947)
3. Aguiar PH, Tsanaclis AM, Tella OI Jr, Plese JP: Proliferation rate of intracranial meningiomas as defined by the monoclonal antibody MIB-1: correlation with peritumoural oedema and other clinicoradiological and histological characteristics. Neurosurg Rev 26:221-228, 2003 (Pubitemid 36835043)
4. Amatya VJ, Takeshima Y, Sugiyama K, Kurisu K, Nishisaka T, Fukuhara T, et al: Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas. Hum Pathol 32:970-975, 2001 (Pubitemid 32911320)
5. Black PM, Morokoff AP, Zauberman J: Surgery for extra-axial tumors of the cerebral convexity and midline. Neurosurgery 62 (6 Suppl 3):1115-1123, 2008
6. Crompton MR, Gautier-Smith PC: The prediction of recurrence in meningiomas. J Neurol Neurosurg Psychiatry 33:80-87, 1970
7. Heros RC: Simpson grade and treatment. Editorial. J Neurosurg 113:1026-1028, 2010
8. Hirsch WL, Sekhar LN, Lanzino G, Pomonis S, Sen CN: Meningiomas involving the cavernous sinus: value of imaging for predicting surgical complications. AJR Am J Roentgenol 160:1083-1088, 1993 (Pubitemid 23141255)
9. Iwai Y, Yamanaka K, Ikeda H: Gamma Knife radiosurgery for skull base meningioma: long-term results of low-dose treatment. J Neurosurg 109:804-810, 2008
10. Jääskeläinen J: Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol 26:461-469, 1986
11. Jellinger K, Slowik F: Histological subtypes and prognostic problems in meningiomas. J Neurol 208:279-298, 1975
12. Kärjä V, Sandell PJ, Kauppinen T, Alafuzoff I: Does protein expression predict recurrence of benign World Health Organization grade I meningioma? Hum Pathol 41:199-207, 2010
13. Kasuya H, Kubo O, Tanaka M, Amano K, Kato K, Hori T: Clinical and radiological features related to the growth potential of meningioma. Neurosurg Rev 29:293-297, 2006
14. Kim YJ, Ketter R, Steudel WI, Feiden W: Prognostic significance of the mitotic index using the mitosis marker anti-phosphohistone H3 in meningiomas. Am J Clin Pathol 128:118-125, 2007 (Pubitemid 47121724)
15. Kleihues P, Burger PC, Scheithauer BW: The new WHO Classification of brain tumours. Brain Pathol 3:255-268, 1993 (Pubitemid 23276692)
16. Kleihues P, Cavanee WK: World Health Organization Classification of Tumours: Pathology and Genetics: Tumours of the Nervous System. Lyon: IARC Press, 2000
17. Kunishio K, Ohmoto T, Furuta T, Matsumoto K, Nishimoto A: Factors influencing the recurrence rate of intracranial meningiomas after surgery. Neurol Med Chir (Tokyo) 34:81-85, 1994 (Pubitemid 24102893)
18. Mathiesen T, Lindquist C, Kihlström L, Karlsson B: Recurrence of cranial base meningiomas. Neurosurgery 39:2-9, 1996 (Pubitemid 26230452)
19. McGovern SL, Aldape KD, Munsell MF, Mahajan A, DeMon tumor grades at recurrence in patients with non-skull base and skull base meningiomas. Clinical article. J Neurosurg 112:925-933, 2010
20. Melamed S, Sahar A, Beller AJ: The recurrence of intracranial meningiomas. Neurochirurgia (Stuttg) 22:47-51, 1979 (Pubitemid 9145588)
21. Mendenhall WM, Morris CG, Amdur RJ, Foote KD, Friedman WA: Radiotherapy alone or after subtotal resection for benign skull base meningiomas. Cancer 98:1473-1482, 2003 (Pubitemid 37151503)
22. Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL: Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 62:18-24, 1985 (Pubitemid 15199399)
23. Nakaguchi H, Fujimaki T, Matsuno A, Matsuura R, Asai A, Suzuki I, et al: Postoperative residual tumor growth of meningioma can be predicted by MIB-1 immunohistochemistry. Cancer 85:2249-2254, 1999 (Pubitemid 29215566)
24. Nakasu S, Fukami T, Jito J, Nozaki K: Recurrence and re-growth of benign meningiomas. Brain Tumor Pathol 26:69-72, 2009
25. Nakasu S, Li DH, Okabe H, Nakajima M, Matsuda M: Significance of MIB-1 staining indices in meningiomas: comparison of two counting methods. Am J Surg Pathol 25:472-478, 2001 (Pubitemid 32240886)
26. Nakaya K, Chernov M, Kasuya H, Izawa M, Hayashi M, Kato K, et al: Risk factors for regrowth of intracranial meningiomas after gamma knife radiosurgery: importance of the histopathological grade and MIB-1 index. Minim Invasive Neurosurg 52:216-221, 2009
27. Naumann M, Meixensberger J: Factors influencing meningioma recurrence rate. Acta Neurochir (Wien) 107:108-111, 1990
28. Pollock BE, Stafford SL, Utter A, Giannini C, Schreiner SA: Stereotactic radiosurgery provides equivalent tumor control to Simpson Grade 1 resection for patients with small- to medium- size meningiomas. Int J Radiat Oncol Biol Phys 55:1000-1005, 2003 (Pubitemid 36287003)
29. Rezanko T, Akkalp AK, Tunakan M, Sari AA: MIB-1 counting methods in meningiomas and agreement among pathologists. Anal Quant Cytol Histol 30:47-52, 2008 (Pubitemid 351312100)
30. Roser F, Samii M, Ostertag H, Bellinzona M: The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases. Acta Neurochir (Wien) 146:37-44, 2004 (Pubitemid 38186205)
31. Schiffer D, Ghimenti C, Fiano V: Absence of histological signs of tumor progression in recurrences of completely resected meningiomas. J Neurooncol 73:125-130, 2005 (Pubitemid 40974032)
32. Sekhar LN, Levine ZT, Sarma S: Grading of meningiomas. J Clin Neurosci 8 Suppl 1:1-7, 2001 (Pubitemid 32666662)
33. Simpson D: The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22-39, 1957
34. Skullerud K, Löken AC: The prognosis in meningiomas. Acta Neuropathol 29:337-344, 1974
35. Smith SJ, Boddu S, Macarthur DC: Atypical meningiomas: WHO moved the goalposts? Br J Neurosurg 21:588-592, 2007 (Pubitemid 350249214)
36. Stafford SL, Perry A, Suman VJ, Meyer FB, Scheithauer BW, Lohse CM, et al: Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. Mayo Clin Proc 73:936-942, 1998 (Pubitemid 28467692)
37. Strassner C, Buhl R, Mehdorn HM: Recurrence of intracranial meningiomas: did better methods of diagnosis and surgical treatment change the outcome in the last 30 years? Neurol Res 31:478-482, 2009
38. Sughrue ME, Kane AJ, Shangari G, Rutkowski MJ, McDermott MW, Berger MS, et al: The relevance of Simpson Grade I and II resection in modern neurosurgical treatment of World Health Organization Grade I meningiomas. Clinical article. J Neurosurg 113:1029-1035, 2010
39. Tyagi A, Chakrabarty A, Franks A: MIB1 proliferation index in meningiomas: does it predict recurrence? A clinicopathological study. Br J Neurosurg 18:357-361, 2004 (Pubitemid 39572266)
40. Vankalakunti M, Vasishta RK, Das Radotra B, Khosla VK: MIB-1 immunolabeling: a valuable marker in prediction of benign recurring meningiomas. Neuropathology 27:407-412, 2007 (Pubitemid 47459713)
41. Vranic A, Popovic M, Cör A, Prestor B, Pizem J: Mitotic count, brain invasion, and location are independent predictors of recurrence-free survival in primary atypical and malignant meningiomas: a study of 86 patients. Neurosurgery 67:1124-1132, 2010
42. Zachenhofer I, Wolfsberger S, Aichholzer M, Bertalanffy A, Roessler K, Kitz K, et al: Gamma-knife radiosurgery for cranial base meningiomas: experience of tumor control, clinical course, and morbidity in a follow-up of more than 8 years. Neurosurgery 58:28-36, 2006 (Pubitemid 43053698)